tci Outpatient Facility Coding Alert - 2017 Issue 6

Coding Update: Don't Miss These Reinstated Drugs on the ASC-Payable List

Sometimes systems “go beserk,” so make sure you’re prepared. The latest Addendum BB from CMS, released April 1, 2017, has reinstated three drugs as eligible for payment separate from the ASC procedure being billed, noted Amy C. Pritchett, BSHA, CPC, CPC-I, CANPC, CASCC, CEDC, CASCC, CRC, CCS, CDMP, CMPM, ICDCT-CM, ICDCT-PCS, CMRS, C-AHI, who spoke at the American Academy of Professional Coders’ recent Healthcon. The drugs are: J1130 (Injection, diclofenac sodium, 0.5 mg), J1566 (Injection, immune globulin, intravenous, lyophilized [eg, powder], not otherwise specified, 500 mg), and J9207 (Injection, ixabepilone, 1 mg). Sometimes, when CMS...

To read the full article, sign in and subscribe to tci Outpatient Facility Coding Alert.

TCI's Outpatient Facility Coding Alert helps your facility stay profitable by covering issues that are important to you — everything from billing strategies and appropriate payment indicators to coding tips and tricks, analysis of industry trends, and so much more. Subscribe today and let our experts make your job easier.

  • Current newsletters added each month
  • Fully searchable archives - over 650 articles
  • ALL years/issues back to 2012 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Outpatient Facility Coding Alert +Archives

free demo
request yours today
for any budget
sign IN
welcome back!